Hepatitis B SIG HBV: Current Management Controversies and the Road to a Cure

Currently, there is groundbreaking research on HBV cure efforts, therapeutic developments for HDV, virologic biomarkers to help individualize antiviral "stopping" strategies in selected populations, and our understanding of concurrent NAFLD and chronic HBV infection. This two-hour symposium reviews emerging data on a potential HBV cure and HDV treatments, novel virologic biomarkers, and the epidemiology and natural history of concurrent HBV/NALFD.